Rich Baxter News Today

Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.03, expectations were $0.58.

Beyfortus, is a new vaccine due for release this fall and is designed for children entering their first RSV season and those that remain vulnerable into their second season.

Beyfortus, is a new vaccine due for release this fall and is designed for children entering their first RSV season and those that remain vulnerable into their second season.

Beyfortus, is a new vaccine due for release this fall and is designed for children entering their first RSV season and those that remain vulnerable into their second season.

Beyfortus, is a new vaccine due for release this fall and is designed for children entering their first RSV season and those that remain vulnerable into their second season.

Plastic debris is strewn across Aldabra’s coastlines, threatening nearby marine ecosystems

More than 200 new cases of the virus popped up in Montana last week, numbers doctors say they don't typically see until January.

More than 200 new cases of the virus popped up in Montana last week, numbers doctors say they don't typically see until January.

More than 200 new cases of the virus popped up in Montana last week, numbers doctors say they don't typically see until January.

More than 200 new cases of the virus popped up in Montana last week, numbers doctors say they don't typically see until January.